Hong Sun
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 10%
- Cell Biology top 10%
- Immunology
- Co-authors
- Hui ZhangLyuben TsvetkovKun‐Huei YehMin WuLeigh Ann HigaNadia J. GavrilovaRamanaiah MamillapalliValia T. Mihaylova
- Topics
- Cancer-related Molecular Pathways (6 papers)Pharmacogenetics and Drug Metabolism (4 papers)Ubiquitin and proteasome pathways (4 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Hong Sun
39 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Molecular Biology 1.2k
- Oncology 770
- Cancer Research 233
- Cell Biology 209
- Immunology 118
Countries citing papers authored by Hong Sun
This map shows the geographic impact of Hong Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Sun more than expected).
Fields of papers citing papers by Hong Sun
This network shows the impact of papers produced by Hong Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Sun. The network helps show where Hong Sun may publish in the future.
Co-authorship network of co-authors of Hong Sun
This figure shows the co-authorship network connecting the top 25 collaborators of Hong Sun. A scholar is included among the top collaborators of Hong Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Sun. Hong Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 30 | |
| 4 | 2 | |
| 5 | 25 | |
| 6 | 9 | |
| 7 | 6 | |
| 8 | 9 | |
| 9 | 11 | |
| 10 | 11 | |
| 11 | 27 | |
| 12 | 27 | |
| 13 | 14 | |
| 14 | 1 | |
| 15 | 15 | |
| 16 | 19 | |
| 17 | 13 | |
| 18 | 22 | |
| 19 | 146 | |
| 20 | 193 |
About Hong Sun
Hong Sun is a scholar working on Oncology, Cancer Research and Pharmacology, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Oncology (770 citations), Molecular Biology (1.2k citations) and Cancer Research (233 citations). Hong Sun has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Hui Zhang, Lyuben Tsvetkov, Kun‐Huei Yeh, Min Wu, Leigh Ann Higa, Nadia J. Gavrilova, Ramanaiah Mamillapalli, Valia T. Mihaylova, Hong Wu and Ryûji Kobayashi. Their work appears in journals such as PLoS ONE, Cancer Research and Current Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.